^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CD14 expression

i
Other names: CD14
Entrez ID:
Related biomarkers:
1year
Farnesylthiosalicylic Acid Through Inhibition of Galectin-3 Improves Neuroinflammation in Alzheimer Disease via Multiple Pathways. (PubMed, CNS Neurosci Ther)
FTS may through inhibiting Gal-3 reduce the expression of TLR4 and CD14 and alleviate Aβ pathology, downregulating Aβ-stimulated TLR2, TLR4, and CD14 expression, and thus alleviate neuroinflammation in Aβ1-42 mice.
Journal • IO biomarker
|
CD14 (CD14 Molecule) • LGALS3 (Galectin 3) • TLR4 (Toll Like Receptor 4) • MAPK8 (Mitogen-activated protein kinase 8) • NDUFA2 (NADH:Ubiquinone Oxidoreductase Subunit A2) • TLR2 (Toll Like Receptor 2)
|
CD14 expression
1year
Potential Association of Maker Expression of Low-Density Neutrophils and Their Phenotypes in Patients with Periodontitis: Control Study. (PubMed, Biomed Res Int)
Regarding subsets, the normal LDN (CD16brightCD62Lbright) was the most predominant phenotype in both periodontitis and control groups. However, the active subset increased in periodontitis compared to normal, indicating their destructive role in periodontitis.
Journal
|
CD14 (CD14 Molecule) • FUT4 (Fucosyltransferase 4) • NDUFA2 (NADH:Ubiquinone Oxidoreductase Subunit A2)
|
CD14 expression
1year
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia. (PubMed, Drugs R D)
Our study identifies additional molecular markers that can be used with molecular features including RAS status to identify patients with AML that may benefit from trametinib treatment.
Journal
|
CD14 (CD14 Molecule) • CLEC7A (C-Type Lectin Domain Containing 7A) • NDUFA2 (NADH:Ubiquinone Oxidoreductase Subunit A2)
|
RAS mutation • CD14 expression
|
Mekinist (trametinib)
over1year
The Prognostic Impact of Tumor Microenvironment and Checkpoint Blockade-Associated Molecules (PD-1, PD-L1, CD163 and CD14) in Nodal Diffuse Large B-cell Lymphoma, NOS. (PubMed, Indian J Hematol Blood Transfus)
In addition, cases that are > 60 years of age, that have Eastern Cooperative Oncology Group (ECOG) performance score ≥ 2, stage IV disease, high International Prognostic Index score score (≥ 3), elevation of LDH, low albumin level, low hemoglobin level, low peripheral blood lymphocyte count, high peripheral blood neutrophil/lymphocyte ratio, high peripheral blood platelet/lymphocyte ratio were found to have worse overall survival. It was concluded that in patients with low number of PD-1 positive tumor-infiltrating lymphocytes have low survival rates and therefore PD-1 expression may be useful in indicating prognosis.
Journal • Checkpoint inhibition • PD(L)-1 Biomarker • IO biomarker • Checkpoint block
|
PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1) • CD163 (CD163 Molecule) • CD14 (CD14 Molecule) • NDUFA2 (NADH:Ubiquinone Oxidoreductase Subunit A2)
|
PD-L1 expression • LDH elevation • PD-1 expression • Albumin-L • CD14 expression • PD-1 positive
almost2years
Impaired monocyte-derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors. (PubMed, Cancer Rep (Hoboken))
The limited success of DC vaccines could be attributed to impaired phenotypic characteristics. These observations suggest that suboptimal characteristics of Mo-DCs generated from cancer patient blood samples might contribute to the limited success of DC vaccines. Consequently, this study underscores the need for alternative strategies to enhance the features of Mo-DCs for more effective cancer immunotherapies.
Journal • IO biomarker
|
CD14 (CD14 Molecule) • CD80 (CD80 Molecule) • CD86 (CD86 Molecule) • NDUFA2 (NADH:Ubiquinone Oxidoreductase Subunit A2)
|
CD14 expression
almost2years
Crystalloid Fluids and Cardiac Surgery (clinicaltrials.gov)
P=N/A, N=15, Suspended, Centre hospitalier de l'Université de Montréal (CHUM) | Trial completion date: Dec 2023 --> Dec 2024 | Recruiting --> Suspended | Trial primary completion date: Dec 2023 --> Dec 2024
Trial completion date • Trial suspension • Trial primary completion date • Surgery
|
CD14 (CD14 Molecule) • NDUFA2 (NADH:Ubiquinone Oxidoreductase Subunit A2)
|
CD14 expression
almost2years
Pericyte Microvesicles as Plasma Biomarkers Reflecting Brain Microvascular Signaling in Patients With Acute Ischemic Stroke. (PubMed, Stroke)
Between 2 and 6 days, proteins were mainly associated with vascular remodeling as indicated by activation of Hedgehog signaling in addition to proangiogenic signals. We demonstrate that the plasma of patients with acute ischemic stroke reflects (1) an early and time-dependent increase of pericyte-derived microvesicles and (2) changes in the protein cargo of microvesicles over time indicating cell signaling specifically related to inflammation and vascular remodeling.
Journal
|
CD14 (CD14 Molecule)
|
CD14 expression
almost2years
Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma. (PubMed, PeerJ)
This study preliminary uncovered a single cell atlas for STAD patients, and Macrophages relevant gene signature and nomogram displayed favorable immunotherapy and prognostic prediction ability. Collectively, our work provides a new insight into the molecular mechanisms and therapeutic approach for LUAD patients.
Journal • IO biomarker
|
CD36 (thrombospondin receptor) • CD14 (CD14 Molecule) • FCGR3A (Fc Fragment Of IgG Receptor IIIa) • NRP1 (Neuropilin 1) • ANXA5 (Annexin A5) • MARCKS (Myristoylated Alanine Rich Protein Kinase C Substrate) • RGS2 (Regulator Of G Protein Signaling 2)
|
CD14 expression
almost2years
Single-cell transcriptome analysis reveals tumoral microenvironment heterogenicity and hypervascularization in human carotid body tumor. (PubMed, J Cell Physiol)
Finally, we identified three types of neuronal cells, including chief cells and sustentacular cells, and elucidated their distinct roles in the pathogenesis of CBT and abnormal proliferation of tumors. Overall, our study provided the first comprehensive characterization of the transcriptional landscape of CBT at scRNA-seq profiles, providing novel insights into the mechanisms underlying its formation.
Journal
|
VEGFA (Vascular endothelial growth factor A) • PDGFRB (Platelet Derived Growth Factor Receptor Beta) • HIF1A (Hypoxia inducible factor 1, alpha subunit) • CD14 (CD14 Molecule) • VIM (Vimentin)
|
HIF1A expression • VIM expression • CD14 expression
2years
Increased Monocytic Myeloid-Derived Suppressor Cells Are Associated with Inferior Overall Survival in Patients with Newly Diagnosed Acute Myeloid Leukemia (ASH 2023)
Medical records were retrospectively reviewed under an IRB approved protocol to identify pts aged ≥ 18 years old with newly diagnosed AML treated with standard cytarabine and anthracycline based chemotherapy from 2004-2017 at Roswell Park Comprehensive Cancer Center... This retrospective analysis suggests that high numbers of marrow mMDSCs are associated with poor overall survival in pts with intermediate risk AML receiving intensive induction therapy. Of note, other risk factors for poor risk disease such as complete molecular profiling were not available. However, our findings support a potential role of mMDSCs in promoting disease recurrence.
Clinical
|
FLT3 (Fms-related tyrosine kinase 3) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • CD14 (CD14 Molecule)
|
FLT3-ITD mutation • CD14 expression
|
cytarabine